Cover Image

Cost-Effectiveness Analysis of Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumor: A Systematic Review

Background: The introduction of tyrosine kinase inhibitor (TKI) therapy has dramatically improved the clinical effectiveness of patients with locally advanced and/or metastatic gastrointestinal stromal tumors (GIST), and this systematic review was conducted aiming at the cost-effectiveness analysis...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mingyang Feng (Author), Yang Yang (Author), Weiting Liao (Author), Qiu Li (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-01-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Lenvatinib Plus Pembrolizumab vs. Chemotherapy in Pretreated Patients With Advanced Endometrial Cancer: A Cost-Effectiveness Analysis
by: Mingyang Feng, et al.
Published: (2022)

Clinical efficacy of second-generation tyrosine kinase inhibitors in imatinib-resistant gastrointestinal stromal tumors: a meta-analysis of recent clinical trials
by: Wu L, et al.
Published: (2014)

Addition of bevacizumab to EGFR tyrosine kinase inhibitors in advanced NSCLC: an updated systematic review and meta-analysis
by: Haosheng Zheng, et al.
Published: (2024)

Comparative Efficacy and Safety of Advanced Intravitreal Therapeutic Agents for Noninfectious Uveitis: A Systematic Review and Network Meta-Analysis
by: Weiting Liao, et al.
Published: (2022)

Ripretinib in combination with tyrosine kinase inhibitor as a late-line treatment option for refractory gastrointestinal stromal tumors: two case reports and literature review
by: Yefan Zhang, et al.
Published: (2023)

Tyrosine phosphatase SHP2 inhibitors in tumor-targeted therapies
by: Zhendong Song, et al.
Published: (2021)

Advances in Small-Molecule C-KIT/PDGFRα Inhibitors for the Treatment of Gastrointestinal Stromal Tumors
by: Xuan Zheng, et al.

Mechanisms of acquired resistance to tyrosine kinase inhibitors
by: Yi-fan Chen, et al.
Published: (2011)

Gastrointestinal Stromal Tumor
Published: (2012)

Downregulation of miR-146a Contributes to Cardiac Dysfunction Induced by the Tyrosine Kinase Inhibitor Sunitinib
by: Li Shen, et al.
Published: (2019)

Safety profile of vascular endothelial growth factor receptor tyrosine-kinase inhibitors in pediatrics: a pharmacovigilance disproportionality analysis
by: Yifei Xue, et al.
Published: (2023)

Iterative Upgrading of Small Molecular Tyrosine Kinase Inhibitors for EGFR Mutation in NSCLC: Necessity and Perspective
by: Jing Zhu, et al.
Published: (2021)

Small bowel gastrointestinal stromal tumor: a retrospective study of 32 cases at a single center and review of the literature
by: Zhou L, et al.
Published: (2018)

Preclinical Evaluation of the Multiple Tyrosine Kinases Inhibitor Anlotinib in Leukemia Stem Cells
by: Yuelong Jiang, et al.
Published: (2022)

Pharmacovigilance study of tyrosine kinase inhibitors: Analysis of adverse reactions
by: Antoan Rangelov, et al.
Published: (2024)

Unresectable gastrointestinal stromal tumors
by: Prema Menon, et al.
Published: (2011)

Pathology of Gastrointestinal Stromal Tumors
by: Wai Chin Foo, et al.
Published: (2012)

Pathology of Gastrointestinal Stromal Tumors
by: Wai Chin Foo, et al.
Published: (2012)

Mechanisms of resistance to EGFR tyrosine kinase inhibitors
by: Lihua Huang, et al.
Published: (2015)

Overcoming EGFR T790M-based Tyrosine Kinase Inhibitor Resistance with an Allele-specific DNAzyme
by: Wei-Yun Lai, et al.
Published: (2014)

Pharmacokinetics and Safety of the Tyrosine Kinase 2 Inhibitor Deucravacitinib in Healthy Chinese Subjects
by: Shan Jing, et al.
Published: (2023)

Impact of MET alterations on targeted therapy with EGFR-tyrosine kinase inhibitors for EGFR-mutant lung cancer
by: Zhe Zhang, et al.
Published: (2019)

EGFR uncommon alterations in advanced non-small cell lung cancer and structural insights into sensitivity to diverse tyrosine kinase inhibitors
by: Haiyan Xu, et al.
Published: (2022)

Exosomes from Bone Marrow Microenvironment-Derived Mesenchymal Stem Cells Affect CML Cells Growth and Promote Drug Resistance to Tyrosine Kinase Inhibitors
by: Xiaoyan Zhang, et al.
Published: (2020)

Advances in nanotechnology-based delivery systems for EGFR tyrosine kinases inhibitors in cancer therapy
by: Xiaohan Zhou, et al.
Published: (2020)

A pan-cancer analysis of oncogenic protein tyrosine phosphatase subfamily PTP4As
by: Mingyang Yu, et al.
Published: (2023)

Gastrointestinal Stromal Tumor Mimicking Ovarian Tumor
by: Özlem Seçilmiş Kerimoğlu, et al.
Published: (2012)

PDGFRA mutant gastrointestinal stromal tumor with composite sclerosing and inflammatory myofibroblastic tumor-like morphology, a case report
by: Xingen Wang, et al.
Published: (2020)

Design, synthesis and evaluation of a series of potential prodrugs of a Bruton's tyrosine kinase (BTK) inhibitor
by: Zhou-Peng Xiao, et al.
Published: (2023)

Transport of six tyrosine kinase inhibitors: active or passive?
by: Richard J. Honeywell, et al.
Published: (2016)

Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
by: Domenico Ribatti
Published: (2010)

Novel Approaches for Efficient Delivery of Tyrosine Kinase Inhibitors
by: Zahra Moradpour, et al.
Published: (2019)

Gastrointestinal stromal tumor (GIST) in an adolescent
by: Musaub Khan, et al.
Published: (2018)

Talking KIT of the gastrointestinal stromal tumors
by: Kim Vaiphei
Published: (2016)

Management of gastrointestinal stromal tumor and acute appendicitis during pregnancy: A case report
by: Wendy Yang, et al.
Published: (2024)

Arterial Hypertension and Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: A Systematic Review and Meta-Analysis
by: Olga Mulas, et al.
Published: (2021)

Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis
by: Miaomiao Yang, et al.
Published: (2024)

SRC Kinase-Mediated Tyrosine Phosphorylation of TUBB3 Regulates Its Stability and Mitotic Spindle Dynamics in Prostate Cancer Cells
by: Alan Alfano, et al.
Published: (2022)

Endoscopic Treatment for Gastrointestinal Stromal Tumors in the Upper Gastrointestinal Tract
by: In Kyung Yoo, et al.
Published: (2020)

Gastrointestinal Stromal Tumor: A Rare Tumor of Childhood
by: Bekir Erdeve, et al.
Published: (2024)